Drug Shortage Report for TEVA-FENTANYL
Report ID | 247779 |
Drug Identification Number | 02311925 |
Brand name | TEVA-FENTANYL |
Common or Proper name | FENTANYL |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FENTANYL |
Strength(s) | 12MCG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 5 |
ATC code | N02AB |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2025-02-01 |
Estimated end date | 2025-04-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2025-02-06 | French | Compare |
v10 | 2025-02-06 | English | Compare |
v9 | 2025-02-03 | French | Compare |
v8 | 2025-02-03 | English | Compare |
v7 | 2025-02-02 | English | Compare |
v6 | 2025-01-30 | French | Compare |
v5 | 2025-01-30 | English | Compare |
v4 | 2025-01-23 | French | Compare |
v3 | 2025-01-23 | English | Compare |
v2 | 2025-01-15 | French | Compare |
v1 | 2025-01-15 | English | Compare |
Showing 1 to 11 of 11